Broadfin Capital LLC 13D/13G Filings for Eiger BioPharmaceuticals, Inc. (EIGR)

Broadfin Capital LLC 13D and 13G filings for Eiger BioPharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-01-04
11:29 am
Sale
2021-01-04 13G Eiger BioPharmaceuticals, Inc.
EIGR
Broadfin Capital LLC 0
0.000%
-41,212decrease
(Position Closed)
Filing